The Sheba Fund For Health Services And Research (R.a.)

Rehovot, Center District

UEI
M8DSJMWZN983
CAGE
3146A
Primary NAICS
622110 General Medical and Surgical Hospitals
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Hospital
  • Non-Profit Organization
Entity structure
International Organization
SAM.gov registration date
Physical address
Prof. Efrayim Katzir St 2, Rehovot, Israel

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Grant subawards

Prime recipient Prime award Amount Awarded
Icahn School Of Medicine At Mount Sinai Planning Year: Prepare and initiate a PK trial - Conduct in vitro spiking experiment with exogenous added herbal compounds to develop LCMS/MS technique for… HT94252510942 $59,423
Rutgers The State University Of New Jersey Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimers pathology and… R01AG061093 $49,680
The Children's Hospital Of Philadelphia Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA - Project Summary Recently, it was shown by Dr. Ben Boursi, Sheba Medical… R01CA259635 $112,050
Rutgers The State University Of New Jersey Systemic and dietary advanced glycation end products in type 2 diabetes-related cognitive decline and incident dementia: effects on Alzheimers pathology and… R01AG061093 $225,139
President And Fellows Of Harvard College Using data from the SMC HCW cohort, this collaboration aims to address the following three issues: 1) To compare immunological and clinical trajectories… U01CA261277 $242,811

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

The Sheba Fund For Health Services And Research (R.A.) is an international non-profit hospital organization focused on medical research and healthcare services. As a prime federal grantee, The Sheba Fund was recently awarded a $2.8 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program to support the Department of Defense Alzheimer's Disease Blood-Testing Initiative from 2022-2026. The Sheba Fund will conduct research to investigate early and non-invasive diagnosis of Alzheimer's disease using blood tests.

As a subawardee, The Sheba Fund has provided a broad range of medical research and services supporting federal grants related to cancer, immunotherapy, microbiome modulation, mitochondrial biology, bioinformatics, and chronic lymphocytic leukemia. These services have been provided under federal grants from the National Institutes of Health, the Department of Defense, and other agencies. Partners have included Rutgers University, the University of California San Francisco, The Children's Hospital of Philadelphia, Massachusetts General Hospital, and Dana-Farber Cancer Institute. The Sheba Fund's subawards have supported research in areas such as apathy components in high Alzheimer's disease risk individuals, traumatic brain injury in older adults, anti-tumor immunity and the gut microbiome, determinants of drug response in chronic lymphocytic leukemia, and the detection of gene fusions and transcriptional aberrations in cancer.

Quick answers

Is The Sheba Fund For Health Services And Research (R.a.) registered in SAM.gov?

Yes. The Sheba Fund For Health Services And Research (R.a.)'s SAM.gov registration is active through March 2, 2027.

What is The Sheba Fund For Health Services And Research (R.a.)'s most recent federal award?

The Sheba Fund For Health Services And Research (R.a.)'s most recent federal grant award is Department of defense alzheimer's disease blood-testing initiative (DOD-adbi): a study to accelerate blood-based… (W81XWH2211081), from Defense Health Agency, on September 30, 2022.

On GovTribe

See The Sheba Fund For Health Services And Research (R.a.)'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors